Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.19
+0.83 (6.21%)
At close: Jun 26, 2026, 4:00 PM EDT
13.00
-1.19 (-8.39%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Contineum Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Contineum Therapeutics stock have an average target of 21, with a low estimate of 14 and a high estimate of 28. The average target predicts an increase of 47.99% from the current stock price of 14.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Contineum Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | +12.76% | May 14, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $26 | Buy | Reiterates | $26 | +83.23% | May 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $29 → $28 | Buy | Maintains | $29 → $28 | +97.32% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $22 | Buy | Maintains | $22 | +55.04% | May 6, 2026 |
| William Blair | William Blair | Buy Reiterates $14 | Buy | Reiterates | $14 | -1.34% | May 6, 2026 |
Financial Forecast
Revenue This Year
6.88M
Revenue Next Year
1.83M
from 6.88M
Decreased by -73.37%
EPS This Year
-1.65
from -2.17
EPS Next Year
-1.81
from -1.65
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.0M | 11.0M | |
| Avg | 6.9M | 1.8M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 59.8% | 461.8% |
| Avg | -73.4% | 12.4% |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -1.65 | -1.81 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.